Literature DB >> 104395

Failure of routine methods in the diagnosis of chronic brucellosis.

J L Carpenter, E C Tramont, W Branche.   

Abstract

A young man who was raised on a farm and developed recurrent subcutaneous abscesses is described. Multiple cultures revealed either no growth or normal skin flora. Routine serologic evaluation for Brucella agglutinins was negative, including serial dilution to greater than 1:1,000 of the patient's sera. Brucella abortus infection was documented by the use of a binding antibody assay to measure the patient's class-specific serologic response and obtaining a positive culture by incorporating methicillin into the culture media to suppress overgrowth of staphylococci. Thus, the potential difficulty in making the diagnosis of brucellosis is demonstrated, and the use of extraordinary means, namely, specific selective media and a binding antibody assay, to make the diagnosis is emphasized.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 104395     DOI: 10.1097/00007611-197901000-00028

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  4 in total

1.  Pathophysiology of the rhesus macaque model for inhalational brucellosis.

Authors:  Lisa N Henning; Stephen M Miller; Dennis H Pak; Amber Lindsay; David A Fisher; Roy E Barnewall; Crystal M Briscoe; Michael S Anderson; Richard L Warren
Journal:  Infect Immun       Date:  2011-11-07       Impact factor: 3.441

2.  Recurrent epidermal cyst infection caused by Brucella melitensis in a diabetic patient.

Authors:  R Dhar; P M Dhar; M Gafoor
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

3.  Spinal cord compression due to Brucella granuloma.

Authors:  N Ceviker; K Baykaner; M Göksel; L Sener; H Alp
Journal:  Infection       Date:  1989 Sep-Oct       Impact factor: 3.553

4.  Estimation of IgG and IgM brucella antibodies in infected and non-infected persons by a radioimmune technique.

Authors:  W G Hewitt; D J Payne
Journal:  J Clin Pathol       Date:  1984-06       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.